Abstract:Background: Mitochondria are dynamic organelles which undergo continuous fission and fusion to maintain their diverse cellular functions. Components of the fission machinery are partly shared between mitochondria and peroxisomes, and inherited defects in two such components (dynamin-related protein (DRP1) and ganglioside-induced differentiation-associated protein 1 (GDAP1)) have been associated with human disease. Deficiency of a third component (mitochondrial fission factor, MFF) was recently reported in one index patient, rendering MFF another candidate disease gene within the expanding field of mitochondrial and peroxisomal dynamics. Here we investigated three new patients from two families with pathogenic mutations in MFF. Methods: The patients underwent clinical examination, brain MRI, and biochemical, cytological and molecular analyses, including exome sequencing. Results: The patients became symptomatic within the first year of life, exhibiting seizures, developmental delay and acquired microcephaly. Dysphagia, spasticity and optic and peripheral neuropathy developed subsequently. Brain MRI showed Leigh-like patterns with bilateral changes of the basal ganglia and subthalamic nucleus, suggestive of impaired mitochondrial energy metabolism. However, activities of mitochondrial respiratory chain complexes were found to be normal in skeletal muscle. Exome sequencing revealed three different biallelic loss-of-function variants in MFF in both index cases. Western blot studies of patient-derived fibroblasts indicated normal content of mitochondria and peroxisomes, whereas immunofluorescence staining revealed elongated mitochondria and peroxisomes. Furthermore, increased mitochondrial branching and an abnormal distribution of fission-mediating DRP1 were observed. Conclusions: Our findings establish MFF loss of function as a cause of disturbed mitochondrial and peroxisomal dynamics associated with early-onset Leigh-like basal ganglia disease. We suggest that, even if laboratory findings are not indicative of mitochondrial or peroxisomal dysfunction, the co-occurrence of optic and/or peripheral neuropathy with seizures warrants genetic testing for MFF mutations.

Unraveling the molecular determinants of a rare human mitochondrial disorder caused by the P144L mutation of FDX2

Biallelic Mutations in the Ferredoxin Reductase Gene Cause Novel Mitochondriopathy with Optic Atrophy

Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability.

A novel complex neurological phenotype due to a homozygous mutation in FDX2

Multilevel Functional and Structural Defects Induced by Two Pathogenic Mitochondrial Trna Mutations

FARS2 Deficiency in Drosophila Reveals the Developmental Delay and Seizure Manifested by Aberrant Mitochondrial Trna Metabolism.

Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance

Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients

FDXR-associated disease: a challenging differential diagnosis with inflammatory peripheral neuropathy

Disturbed mitochondrial and peroxisomal dynamics due to loss of MFF causes Leigh-like encephalopathy, optic atrophy and peripheral neuropathy

Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome

MFN2 mutations in Charcot–Marie–Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics

Mutations in FASTKD2 Are Associated with Mitochondrial Disease with Multi-Oxphos Deficiency.

Mitochondrial Gene Defect in Patients with Chronic Progressive External Ophthalmoplegia.

A MERRF/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation

A human mitofusin 2 mutation can cause mitophagic cardiomyopathy

Impact of mutations within the [Fe-S] cluster or the lipoic acid biosynthesis pathways on mitochondrial protein expression profiles in fibroblasts from patients

A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy

Methionyl-tRNA Formyltransferase (MTFMT) Deficiency Mimicking Acquired Demyelinating Disease

Clinical and Biochemical Features in a Patient With Mitochondrial Fission Factor Gene Alteration

A cryptic pathogenic NDUFV1 variant identified by RNA-seq in a patient with normal complex I activity in muscle and transient magnetic resonance imaging changes